BULL PHARMA: RISKS AND REALITIES

The rise of “rogue pharma” companies presents a serious risks to patient health, but the reality is often more intricate than first reports suggest. These organizations , frequently operating outside conventional regulatory frameworks, may offer different therapies at reduced costs, appealing to